Nearly Nonsurgical Weight Loss Treatment for Morbidly Obese Targets Hunger Pain
Are you among the many who cannot lose weight because of those unrelenting hunger pains? New research shows that there is a new nearly nonsurgical weight loss treatment that targets hunger pain and helps severely obese people lose weight.
According to a press release from the Society of Interventional Radiology you can “BEAT” your hunger pains into submission with a safe, nonsurgical weight loss treatment called “Bariatric Embolization of Arteries for the Treatment of Obesity (BEAT Obesity) that they say is a safe alternative to more invasive bariatric weight loss procedures.
The research behind this novel weight loss procedure was presented at the Society of Interventional Radiology’s 2016 Annual Scientific Meeting following a small trial consisting of morbidly obese patients recruited for the study.
WHAT IS BEAT and HOW DOES IT WORK?
Basically, BEAT works by inhibiting the hunger hormone ghrelin by inserting a small catheter through a tiny incision at the wrist or groin, from which radiographic imaging helps guide the catheter to the fundus region of the stomach where ghrelin is produced. Once the catheter is in place, tiny beads are injected into blood vessels to block blood flow to the fundus and thereby inhibit ghrelin.
After treatment, a BEAT procedure patient is monitored for weight loss, ghrelin levels, hunger and satiety assessments, quality-of-life assessments, blood pressure, and other markers that may indicate an adverse event at one, three and six month intervals following the procedure.
BEAT STUDY RESULTS TOWARD WEIGHT LOSS
According to the press release by the Society of Interventional Radiology, the researchers found in the pilot trial study of 7 morbidly obese patients that not only did the BEAT procedure prove to be safe, but effective as well:
• The seven patients receiving the bariatric embolization experienced no major adverse events.
• All patients demonstrated weight loss and dramatic hunger reduction levels after the procedure.
• Ghrelin hunger hormone levels decreased, while quality-of-life scores improved.
• In the first month following BAE, participants had an average excess-weight loss of 5.9 percent.
• After six months, the participants’ excess-weight loss increased to an average of 13.3 percent.
“These early results demonstrate that BAE (bariatric arterial embolization) appears to be effective in helping patients lose a significant amount of weight in the short and intermediate term,” said Clifford Weiss, M.D., FSIR, associate professor of radiology and radiological science and director of interventional radiology research. “We’re excited about the promise of bariatric arterial embolization as another tool for health care providers to offer patients in the effort to curb this epidemic. As this study expands and includes more patients, we will be able to gain more insight into the efficacy of BAE and the role interventional radiology can play in the critical battle against obesity.”
For more about weight loss procedures, here is one about a lesser used surgical method that actually results in more weight loss than standard gastric bypass surgery.
Society of Interventional Radiology press release “Bariatric Embolization of Arteries for the Treatment of Obesity (BEAT Obesity): Three Month Safety and Efficacy Data.”
Image courtesy of Pixabay